BioSpace News Archive

Drug Development

Akari Therapeutics Reports Second Quarter 2019 Financial Results And Highlights Recent Clinical Progress

Akari Therapeutics, Plc announced financial results for the second quarter ended June 30, 2019 and recent clinical progress.

August 30, 2019
·
10 min read
BioCapital

New Momentum Magnetic Particle Imaging Scanner to be installed in Baltimore

A Magnetic Particle Imaging scanner will be installed in The F.M. Kirby Imaging Center at Kennedy Krieger Institute in Baltimore, Maryland.

August 30, 2019
·
2 min read
BioMidwest

Vaccine Breakthrough Published in Proceedings of the National Academy of Sciences

BioGenerator-supported startup noted for its ‘promising technology’ to more quickly and affordably bring vaccines to market

August 30, 2019
·
2 min read
Bittium Exhibits Its Cardiac Monitoring Products and Solutions at ESC Congress 2019

Bittium Exhibits Its Cardiac Monitoring Products and Solutions at ESC Congress 2019

August 30, 2019
·
3 min read
Drug Development

Novartis’ Cancer Drug Arzerra Beats Out Sanofi’s Aubagio in Treating Multiple Sclerosis

The trials met the primary endpoints, with ofatumumab demonstrating a highly significant and clinically meaningful decrease in the number of confirmed relapses. The trials also hit key secondary endpoints, delaying the time to confirmed disability progression.

August 30, 2019
·
2 min read
·
Mark Terry
New Research Could Help Personalize Treatment for Myasthenia Gravis

Researchers with the University of Alberta recently identified a unique biological marker for myasthenia gravis that might be used for a diagnostic test and to predict the course of the disease. It may also have implications for defining more personalized treatments.

August 30, 2019
·
2 min read
·
Mark Terry
Genetown

Researchers Target NAFLD, NASH Using Lab-on-a-Chip Technology

For years, companies have struggled to develop treatments for non-alcoholic fatty liver disease (NAFLD), a disease that is growing across the world and is predicted to become the main cause of chronic liver problems and the need for liver transplantation.

August 30, 2019
·
2 min read
·
Alex Keown
Policy

U.S. District Court Invalidates Amgen Patents Over Cholesterol Med

In an ongoing battle between Regeneron Pharmaceuticals and Sanofi versus Amgen over PCSK9 inhibitors to treat high cholesterol, a U.S. district court invalidated Amgen’s patents for Repatha.

August 30, 2019
·
3 min read
·
Mark Terry
Drug Development

AbbVie Out $5.8 Billion After Scrapping Rova-T Program

AbbVie announced that the Phase III MERU trial evaluating Rova-T as first-line maintenance therapy for advanced small-cell lung cancer, failed to demonstrate a survival benefit following a pre-planned interim analysis.

August 30, 2019
·
2 min read
·
Alex Keown